Literature DB >> 2009642

Antibodies to extracellular matrix proteins in the sera of MRL-lpr mice.

L G Ratkay1, J Tonzetich, J D Waterfield.   

Abstract

Autoimmune MRL-lpr mice develop a spontaneous arthritis displaying similar articular and extra-articular features to rheumatoid arthritis in humans. In this study we used an ELISA assay to evaluate the serological responses of MRL-lpr mice to select extracellular matrix proteins associated with the joint. Significant levels of antibodies to collagens types I, II, III, IV, and V were demonstrated starting between 17 and 20 weeks of age. Moreover, the sera contained a strong reactivity to fibronectin. Responses to proteoglycans and laminin were weaker but still detectable. Specificity studies on pooled sera from MRL-lpr mice suggest that the autoantibodies produced are highly cross-reactive. The results indicate that the MRL-lpr mouse strain exhibits similar anti-extracellular matrix antibody profiles to those seen in varying frequencies in the sera and synovial fluid of patients with rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2009642     DOI: 10.1016/0090-1229(91)90021-2

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  5 in total

1.  Serum laminin and basic fibroblast growth factor concentrations in patients with complicated Plasmodium falciparum malaria.

Authors:  H Burgmann; S Looareesuwan; C Viravan; S Vanijanonta; K Zedwitz-Liebenstein; H Vorbach; W Graninger
Journal:  J Clin Immunol       Date:  1996-09       Impact factor: 8.317

2.  Genetic dissection of lupus pathogenesis: a recipe for nephrophilic autoantibodies.

Authors:  C Mohan; L Morel; P Yang; H Watanabe; B Croker; G Gilkeson; E K Wakeland
Journal:  J Clin Invest       Date:  1999-06       Impact factor: 14.808

3.  In vitro detection of apoptotic stimuli by use of the HL-60 myeloid leukemic cell line.

Authors:  J L Shellhaas; S H Zuckerman
Journal:  Clin Diagn Lab Immunol       Date:  1995-09

4.  Photodynamic therapy; a comparison with other immunomodulatory treatments of adjuvant-enhanced arthritis in MRL-lpr mice.

Authors:  L G Ratkay; R K Chowdhary; H C Neyndorff; J Tonzetich; J D Waterfield; J G Levy
Journal:  Clin Exp Immunol       Date:  1994-03       Impact factor: 4.330

5.  Evaluation of a model for post-partum arthritis and the role of oestrogen in prevention of MRL-lpr associated rheumatic conditions.

Authors:  L G Ratkay; D Zhang; J Tonzetich; J G Levy; J D Waterfield
Journal:  Clin Exp Immunol       Date:  1994-10       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.